Advertisement

Ventricular Tachycardia in Granulomatous Myocarditis

Role of Catheter Ablation

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cardiac Electrophysiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Duke C.
        • Rosenthal E.
        Sudden death caused by cardiac sarcoidosis in childhood..
        J Cardiovasc electrophysiol. 2002; 13: 939-942
        • Thachil A.
        • Christopher J.
        • Sastry B.K.
        • et al.
        Monomorphic ventricular tachycardia and mediastinaladenopathy due to granulomatous infiltration in patients with preserved ventricular function..
        J Am Coll Cardiol. 2011; 58: 48-55
        • Matsui Y.
        • Iwai K.
        • Tachibana T.
        • et al.
        Clinicopathological study of fatal myocardial sarcoidosis.
        Ann N Y Acad Sci. 1976; 278: 455-469
        • Winters S.L.
        • Cohen M.
        • Greenberg S.
        • et al.
        Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device.
        J Am Coll cCardiol. 1991; 18: 937-943
        • Furushima H.
        • Chinushi M.
        • Sugiura H.
        • et al.
        Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome.
        ClinCardiol. 2004; 27: 217-222
        • Sharma S.K.
        • Mohan A.
        Tuberculosis: from an incurable scourge to a curable disease—journey over a millennium.
        Indian J Med Res. 2013; 137: 455-493
        • Roberts W.C.
        • McAllister H.A.
        • Ferrans V.J.
        Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11).
        Am J Med. 1977; 63: 86-108
        • Veinot J.P.
        • Johnston B.
        Cardiac sarcoidosis--an occult cause of sudden death: a case report and literature review.
        J Forensic Sci. 1998; 43: 715-717
        • Wallis P.J.
        • Branfoot A.C.
        • Emerson P.A.
        Sudden death due to myocardial tuberculosis.
        Thorax. 1984; 39: 155-156
        • Rose A.G.
        Cardiac tuberculosis. A study of 19 patients.
        Arch Pathol Lab Med. 1987; 111: 422-426
        • Schnitzer R.
        Myocardial tuberculosis with paroxysmal ventricular tachycardia.
        Br Heart J. 1947; 9: 213-219
        • Agarwal R.
        • Malhotra P.
        • Awasthi A.
        • et al.
        Tuberculous dilated cardiomyopathy: an under-recognized entity?.
        BMC Infect Dis. 2005; 5: 29
        • Gulati G.S.
        • Kothari S.S.
        Diffuse infiltrative cardiac tuberculosis.
        Ann Pediatr. 2011; 4: 87-89
        • Koplan B.A.
        • Soejima K.
        • Baughman K.
        • et al.
        Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation.
        Heart Rhythm. 2006; 3: 924-929
        • Banba K.
        • Kusano K.F.
        • Nakamura K.
        • et al.
        Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis.
        Heart Rhythm. 2007; 4: 1292-1299
        • Soejima K.
        • Yada H.
        The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities.
        J Cardiovasc electrophysiol. 2009; 20: 578-583
        • Terasaki F.
        • Ishizaka N.
        Deterioration of cardiac function during the progression of cardiac sarcoidosis: diagnosis and treatment.
        Intern Med. 2014; 53: 1595-1605
        • Padala S.K.
        • Peaslee S.
        • Sidhu M.S.
        • et al.
        Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis.
        Int J Cardiol. 2017; 227: 565-570
        • Bargout R.
        • Kelly R.F.
        Sarcoid heart disease: clinical course and treatment.
        Int J Cardiol. 2004; 97: 173-182
        • Uusimaa P.
        • Ylitalo K.
        • Anttonen O.
        • et al.
        Ventricular tachyarrhythmia as a primary presentation of sarcoidosis.
        Europace. 2008; 10: 760-766
        • Kirchhof P.
        • Eckardt L.
        • Haverkamp
        • et al.
        IntracardiacTuberculoma causing “idiopathic” ventricular tachycardia in a patient without Detectable heart disease.
        J Cardiovasc Electrophysiol. 2001; 12: 118
        • Latcu D.G.
        • Duparc A.
        • Chabbert V.
        • et al.
        Systemic sarcoidosis revealed by ventricular tachycardia: electrocardiography and MRI correspondence.
        Pacing Clin Electrophysiol. 2007; 30: 1566-1570
        • Kumar S.
        • Barbhaiya C.
        • Nagashima K.
        • et al.
        Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation.
        Circ Arrhythm Electrophysiol. 2015; 8: 87-93
        • Naruse Y.
        • Sekiguchi Y.
        • Nogami A.
        • et al.
        Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis.
        Circ Arrhythm Electrophysiol. 2014; 7: 407-413
        • Panda S.
        • Kaur D.
        • Lalukota K.
        • et al.
        Pleomorphism during ventricular tachycardia: a Distinguishing Feature between cardiac sarcoidosis and idiopathic VT.
        Pacing Clin Electrophysiol. 2015; 38: 694-699
        • Yalagudri S.
        • Zin Thu N.
        • Devidutta S.
        • et al.
        Tailored approach for management of ventricular tachycardia in cardiac sarcoidosis.
        J Cardiovasc Electrophysiol. 2017; https://doi.org/10.1111/jce.13228
        • Blankstein R.
        • Osborne M.
        • Naya M.
        • et al.
        Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
        J Am Coll Cardiol. 2014; 63: 329-336
        • Birnie D.H.
        • Sauer W.H.
        • Bogun F.
        • et al.
        HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.
        Heart Rhythm. 2014; 11: 1305-1323
        • Yodogawa K.
        • Seino Y.
        • Ohara T.
        • et al.
        Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis.
        Ann Noninvasive Electrocardiol. 2011; 16: 140-147
        • Tung R.
        • Bauer B.
        • Schelbert H.
        • et al.
        Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: the potential role of occult inflammation in arrhythmogenesis.
        Heart Rhythm. 2015; 12: 2488-2498
        • Walsh M.J.
        Systemic sarcoidosis with refractory ventricular tachycardia and heart failure.
        Br Heart J. 1978; 40: 931-933
        • Jefic D.
        • Joel B.
        • Good E.
        • et al.
        Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry.
        Heart Rhythm. 2009; 6: 189-195
        • Kaur D.
        • Roukoz H.
        • Shah M.
        • et al.
        Impact of the inflammation on the outcomes of catheter ablation of drug-refractory ventricular tachycardia in cardiac sarcoidosis [published online ahead of print, 2020 Jan 9].
        J Cardiovasc Electrophysiol. 2020; https://doi.org/10.1111/jce.14341
        • Shirai Yasuhiro
        • Goya Masahiko
        • Tao Susumu
        • et al.
        Delayed Purkinje potential during sinus rhythm in cardiac sarcoidosis with multiple focal Purkinje ventricular tachycardias: ablation target or bystander?.
        Heart Rhythm Case Rep. 2022; https://doi.org/10.1016/j.hrcr.2022.05.005
        • Noda T.
        • Suyama K.
        • Shimizu W.
        • et al.
        Ventricular tachycardia with figure eight pattern originating from the right ventricle in a patient with cardiac sarcoidosis.
        Pacing Clin Electrophysiol. 2004; 27: 561-562
        • Santucci P.A.
        • Morton J.B.
        • PickenMM
        • et al.
        Electranatomic mapping of the right ventricle in a patient with a giant epsilon wave, ventricular tachycardia and cardiac sarcoidosis.
        J Cardivasc electrophysiol. 2004; 15: 1091-1094
        • Dechering D.G.
        • Kochhauser S.
        • Wasmer K.
        • et al.
        Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenicrightventricular cardiomyopathy.
        Heart Rhythm. 2013; 10: 158-164
        • Sekiguchi M.
        • Hiroe M.
        • Take M.
        • et al.
        Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy.II. Myocarditis.
        Jpncirc J. 1980; 44: 264-273
        • Shelke A.B.
        • Aurangabadkar H.U.
        • Bradfield J.S.
        • et al.
        Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis.
        Int J Cardiol. 2017; 228: 717-722